Igene Biotechnology, Inc. (IGNE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2009 | 990.93 Thousand USD | -71.17% |
| 2008 | 3.43 Million USD | 539.0% |
| 2007 | 537.97 Thousand USD | 75.03% |
| 2006 | 307.37 Thousand USD | 0.0% |
| 2003 | 642.08 Thousand USD | -70.48% |
| 2002 | 2.17 Million USD | -5.5% |
| 2001 | 2.3 Million USD | 51.33% |
| 2000 | 1.52 Million USD | -14.23% |
| 1999 | 1.77 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2010 Q1 | 147.59 Thousand USD | -44.91% |
| 2010 Q2 | 126.63 Thousand USD | -14.21% |
| 2010 Q3 | 95.44 Thousand USD | -24.63% |
| 2009 Q2 | 293.69 Thousand USD | -15.24% |
| 2009 FY | 990.93 Thousand USD | -71.17% |
| 2009 Q4 | 267.94 Thousand USD | 223.74% |
| 2009 Q1 | 346.52 Thousand USD | -66.49% |
| 2009 Q3 | 82.76 Thousand USD | -71.82% |
| 2008 Q1 | 825.51 Thousand USD | 53.51% |
| 2008 Q4 | 1.03 Million USD | 38.34% |
| 2008 Q3 | 747.42 Thousand USD | -10.04% |
| 2008 Q2 | 830.81 Thousand USD | 0.64% |
| 2008 FY | 3.43 Million USD | 539.0% |
| 2007 Q1 | 11.87 Thousand USD | -84.5% |
| 2007 Q2 | 42.31 Thousand USD | 256.31% |
| 2007 FY | 537.97 Thousand USD | 75.03% |
| 2007 Q4 | 537.75 Thousand USD | 1096.49% |
| 2007 Q3 | -53.96 Thousand USD | -227.54% |
| 2006 FY | 307.37 Thousand USD | 0.0% |
| 2006 Q4 | 76.59 Thousand USD | 103.31% |
| 2006 Q3 | 37.67 Thousand USD | -67.75% |
| 2006 Q2 | 116.8 Thousand USD | 53.08% |
| 2006 Q1 | 76.3 Thousand USD | 0.0% |
| 2005 Q3 | 8453.00 USD | 0.0% |
| 2004 Q1 | 56.34 Thousand USD | 19.08% |
| 2004 Q2 | 215.08 Thousand USD | 281.72% |
| 2004 Q3 | 6197.00 USD | -97.12% |
| 2003 Q2 | 19.58 Thousand USD | -95.09% |
| 2003 FY | 642.08 Thousand USD | -70.48% |
| 2003 Q1 | 398.62 Thousand USD | 342.54% |
| 2003 Q3 | 176.56 Thousand USD | 801.76% |
| 2003 Q4 | 47.31 Thousand USD | -73.2% |
| 2002 Q2 | 680.93 Thousand USD | -10.91% |
| 2002 FY | 2.17 Million USD | -5.5% |
| 2002 Q1 | 764.35 Thousand USD | 30.38% |
| 2002 Q4 | -164.35 Thousand USD | -115.3% |
| 2002 Q3 | 1.07 Million USD | 57.74% |
| 2001 Q3 | 769.15 Thousand USD | 34.38% |
| 2001 Q2 | 572.36 Thousand USD | 50.95% |
| 2001 FY | 2.3 Million USD | 51.33% |
| 2001 Q1 | 379.18 Thousand USD | 1.85% |
| 2001 Q4 | 586.26 Thousand USD | -23.78% |
| 2000 Q3 | 451.74 Thousand USD | 11.68% |
| 2000 Q4 | 372.29 Thousand USD | -17.59% |
| 2000 Q2 | 404.48 Thousand USD | 38.29% |
| 2000 Q1 | 292.49 Thousand USD | 0.0% |
| 2000 FY | 1.52 Million USD | -14.23% |
| 1999 FY | 1.77 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Allied Energy Corporation | 403.19 Thousand USD | -145.769% |
| Earth Alive Clean Technologies Inc. | 5.04 Million USD | 80.358% |
| Lotus Bio-Technology Development Corp. | - USD | -Infinity% |
| MagIndustries Corp. | 24.19 Million USD | 95.905% |
| Itafos Inc. | 27.99 Million USD | 96.46% |
| Potash America, Inc. | 320.37 Thousand USD | -209.301% |
| Yara International ASA | 3.02 Billion USD | 99.967% |
| Yara International ASA | 3.02 Billion USD | 99.967% |